Department of Obstetrics and Gynecology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Gynecol Endocrinol. 2021 Oct;37(10):885-890. doi: 10.1080/09513590.2021.1878137. Epub 2021 Feb 1.
To assess the predictive value of serum progesterone/estradiol (P/E) and serum progesterone/follicle (P/F) ratios on the reproductive outcomes of women without elevated trigger-day progesterone levels undergoing GnRH-antagonist IVF ( fertilization)/ICSI (intracytoplasmic sperm injection) cycles.
This was a retrospective cohort study in a university teaching hospital conducted between January 2017 and December 2019. Couples who underwent assisted reproduction cycles were evaluated. Initially, 978 cycles were evaluated and only GnRH antagonist cycles ( = 505) without elevated trigger-day progesterone levels were analyzed after respecting exclusion criteria.
A total of 505 cycles were analyzed after the exclusion criteria were met. The clinical pregnancy rate, ongoing pregnancy rate, and live birth rate were 45.5%, 30.9%, and 27.8%, respectively. Cutoff values of P/E and P/F ratios that were discriminative for achieving or not achieving clinical pregnancy were 0.36 and 0.17, respectively. The clinical pregnancy rates were found to be significantly different between below and above P/E cutoff values (49.8% vs. 40.1%, respectively, = .031), while there were no significant differences between below and above P/F cutoff values regarding the pregnancy outcomes.
The P/E and P/F ratios were found to be more efficient and reliable markers than serum progesterone level alone in predicting the reproductive outcomes of assisted reproduction cycles without a premature rise in serum progesterone levels. A P/E ratio ≤0.36 and a P/F ratio ≤0.17 significantly improved the cycle outcomes.
评估血清孕激素/雌二醇(P/E)和血清孕激素/卵泡(P/F)比值对接受 GnRH 拮抗剂 IVF(受精)/ICSI(胞浆内精子注射)周期且未升高触发日孕激素水平的女性的生殖结局的预测价值。
这是一项在大学教学医院进行的回顾性队列研究,于 2017 年 1 月至 2019 年 12 月期间进行。评估接受辅助生殖周期的夫妇。最初评估了 978 个周期,仅在尊重排除标准后分析了无升高触发日孕激素水平的 GnRH 拮抗剂周期( = 505)。
符合排除标准后共分析了 505 个周期。临床妊娠率、持续妊娠率和活产率分别为 45.5%、30.9%和 27.8%。预测是否达到临床妊娠的 P/E 和 P/F 比值的截断值分别为 0.36 和 0.17。低于和高于 P/E 截断值的妊娠率差异有统计学意义(分别为 49.8%和 40.1%, = .031),而低于和高于 P/F 截断值的妊娠结局差异无统计学意义。
与单独血清孕激素水平相比,P/E 和 P/F 比值是预测无血清孕激素提前升高的辅助生殖周期生殖结局的更有效和可靠的标志物。P/E 比值≤0.36 和 P/F 比值≤0.17 显著改善了周期结局。